ASTRAZENECA PLC (AZN)
Clinical trial NCT05211895 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2030-10-01 → 2027-09-08 3. primary completion date: 2028-07-12 → 2026-08-10 4. enrollment: 860 → 791 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical